BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10070613)

  • 1. Identification of new medium-chain acylcarnitines present in urine of a patient with medium-chain acyl-CoA dehydrogenase deficiency.
    Libert R; Van Hoof F; Thillaye M; Vincent MF; Nassogne MC; Stroobant V; de Hoffmann E; Schanck A
    J Inherit Metab Dis; 1999 Feb; 22(1):9-18. PubMed ID: 10070613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency.
    Roe CR; Millington DS; Maltby DA; Bohan TP; Kahler SG; Chalmers RA
    Pediatr Res; 1985 May; 19(5):459-66. PubMed ID: 4000772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.
    Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA
    Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of urinary acylglycines and acylcarnitines as diagnostic markers of medium-chain acyl-CoA dehydrogenase deficiency.
    Rinaldo P; O'Shea JJ; Goodman SI; Miller LV; Fennessey PV; Whelan DT; Hill RE; Tanaka K
    J Inherit Metab Dis; 1989; 12 Suppl 2():325-8. PubMed ID: 2512435
    [No Abstract]   [Full Text] [Related]  

  • 5. Acylcarnitines in the urine of a patient with medium chain acyl-CoA dehydrogenase (MCAD) deficiency and in normal children.
    Schmidt-Sommerfeld E; Penn D; Kerner J; Bieber LL
    Prog Clin Biol Res; 1990; 321():403-9. PubMed ID: 2326301
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy.
    Westermann CM; Dorland L; Votion DM; de Sain-van der Velden MG; Wijnberg ID; Wanders RJ; Spliet WG; Testerink N; Berger R; Ruiter JP; van der Kolk JH
    Neuromuscul Disord; 2008 May; 18(5):355-64. PubMed ID: 18406615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of carnitine and specific acylcarnitines by high-performance liquid chromatography: application to normal human urine and urine from patients with methylmalonic aciduria, isovaleric acidemia or medium-chain acyl-CoA dehydrogenase deficiency.
    Minkler PE; Hoppel CL
    J Chromatogr; 1993 Apr; 613(2):203-21. PubMed ID: 8491807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of phenylpropionylcarnitine, a new metabolite of phenylpropionic acid, in a patient with medium chain acyl-CoA dehydrogenase deficiency.
    Moore R; Millington DS; Norwood D; Kodo N; Robinson P; Glasgow JF
    J Inherit Metab Dis; 1990; 13(3):325-9. PubMed ID: 2122094
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
    Chalmers RA; Roe CR; Stacey TE; Hoppel CL
    Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of acylcarnitines as their N-demethylated ester derivatives by gas chromatography-chemical ionization mass spectrometry.
    Huang ZH; Gage DA; Bieber LL; Sweeley CC
    Anal Biochem; 1991 Nov; 199(1):98-105. PubMed ID: 1807168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medium-chain acyl-CoA dehydrogenase deficiency.
    Millington DS; Roe CR
    N Engl J Med; 1989 May; 320(18):1219. PubMed ID: 2710197
    [No Abstract]   [Full Text] [Related]  

  • 12. Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency.
    Pourfarzam M; Morris A; Appleton M; Craft A; Bartlett K
    Lancet; 2001 Sep; 358(9287):1063-4. PubMed ID: 11589939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium-chain acyl-CoA dehydrogenase deficiency: metabolic effects and therapeutic efficacy of long-term L-carnitine supplementation.
    Treem WR; Stanley CA; Goodman SI
    J Inherit Metab Dis; 1989; 12(2):112-9. PubMed ID: 2502671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of abnormal urinary metabolites in the newborn period in medium-chain acyl-CoA dehydrogenase deficiency.
    Bennett MJ; Coates PM; Hale DE; Millington DS; Pollitt RJ; Rinaldo P; Roe CR; Tanaka K
    J Inherit Metab Dis; 1990; 13(5):707-15. PubMed ID: 2246856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octanoylglucuronide excretion in patients with a defective oxidation of medium-chain fatty acids.
    Duran M; Ketting D; van Vossen R; Beckeringh TE; Dorland L; Bruinvis L; Wadman SK
    Clin Chim Acta; 1985 Nov; 152(3):253-60. PubMed ID: 4064333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of free carnitine, individual short- and medium-chain acylcarnitines, and total carnitine in plasma by high-performance liquid chromatography.
    Minkler PE; Hoppel CL
    Anal Biochem; 1993 Aug; 212(2):510-8. PubMed ID: 8214594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of acyl-CoA dehydrogenases in muscle and liver and identification of four new cases of medium-chain acyl-CoA dehydrogenase deficiency associated with systemic carnitine deficiency.
    Zierz S; Engel AG; Romshe CA
    Adv Neurol; 1988; 48():231-7. PubMed ID: 3334785
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel glycine conjugates in medium-chain acyl-CoA dehydrogenase deficiency.
    Pitt JJ
    J Inherit Metab Dis; 1993; 16(2):392-8. PubMed ID: 8411999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes.
    Roe CR; Millington DS; Maltby DA; Kinnebrew P
    J Pediatr; 1986 Jan; 108(1):13-8. PubMed ID: 3944676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic deficiency of short-chain acyl-coenzyme A dehydrogenase in cultured fibroblasts from a patient with muscle carnitine deficiency and severe skeletal muscle weakness.
    Coates PM; Hale DE; Finocchiaro G; Tanaka K; Winter SC
    J Clin Invest; 1988 Jan; 81(1):171-5. PubMed ID: 3335634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.